2025 third_quarter Filing
Q3Income
$50K
Filed
October 20, 2025
Lobbying Activities
Health IssuesView all
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. 340B, Vaccine issues.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Medicare/MedicaidView all
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (6)
SUSAN HIRSCHMANN
mr CHRISTOPHER W HATCHER
mr MATTHEW B HOEKSTRA
CHRISTOPHER E. WILCOX
LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings